Buckingham Strategic Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-1,159
Closed -$284K – 549
2020
Q4
$284K Buy
+1,159
New +$299K 0.01% 430
2020
Q2
– Sell
-875
Closed -$277K – 414
2020
Q1
$277K Buy
875
+33
+4% +$10K 0.03% 355
2019
Q4
$250K Buy
+842
New +$234K 0.02% 392
2019
Q3
– Sell
-1,279
Closed -$299K – 433
2019
Q2
$299K Sell
1,279
-389
-23% -$89.8K 0.03% 343
2019
Q1
$394K Buy
1,668
+860
+106% +$271K 0.05% 268
2018
Q4
$243K Sell
808
-38
-4% -$12.1K 0.04% 299
2018
Q3
$299K Buy
846
+40
+5% +$13.8K 0.05% 272
2018
Q2
$234K Buy
+806
New +$227K 0.04% 309
2018
Q1
– Sell
-657
Closed -$209K – 315
2017
Q4
$209K Buy
+657
New +$211K 0.04% 292
2016
Q3
– Sell
-865
Closed -$209K – 231
2016
Q2
$209K Buy
865
+15
+2% +$3.95K 0.07% 219
2016
Q1
$221K Buy
850
+106
+14% +$28K 0.07% 200
2015
Q4
$228K Sell
744
-1
-0.1% -$287 0.08% 172
2015
Q3
$217K Buy
745
+90
+14% +$29.7K 0.08% 181
2015
Q2
$265K Hold
655
– – 0.09% 173
2015
Q1
$277K Hold
655
– – 0.1% 153
2014
Q4
$222K Buy
655
+21
+3% +$6.79K 0.09% 180
2014
Q3
$210K Buy
+634
New +$209K 0.09% 161
2014
Q2
– Sell
-671
Closed -$205K – 177
2014
Q1
$205K Buy
+671
New +$213K 0.09% 141

Other funds holding BIIB

Buckingham Strategic Wealth's BIIB Position: Q1 2021 in Review

Buckingham Strategic Wealth sold out of Biogen (BIIB) in Q1 2021, closing a stake of 1,159 shares — an estimated $284K sold.

Buckingham Strategic Wealth first reported a position in BIIB in Q1 2014 and held it in 18 quarters. The position peaked at $394K in Q1 2019. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Buckingham Strategic Wealth reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Buckingham Strategic Wealth sold 1,159 Biogen shares in Q1 2021, an estimated $284K.
  • Buckingham Strategic Wealth first reported a position in Biogen in Q1 2014 and held it in 18 quarters.
  • Buckingham Strategic Wealth's Biogen position peaked at $394K in Q1 2019.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Buckingham Strategic Wealth's 13F filing for Q1 2021, filed 30 Apr 2021.